Denali Growth Partners
545 Boylston Street, Suite 1101, Boston, MA, 02116, United States
Overview
Denali Growth Partners is a growth equity firm focused on partnering with healthcare technology companies.
- Total investments
- 6
- Lead investments
- 6
- Investments · 12mo
- 2
- Active investors
- 4
Investment portfolio
- Luxonis
Led · Series A · Jul 2026
Founded in 2019, Luxonis develops the OAK camera family and the open-source DepthAI software to provide on-device visual perception for robotics and automated systems. The company’s DepthAI SDK has reached 6 million downloads and it serves thousands of customers, including more than 60 Fortune 500 companies and 17 of the Dow Jones 30. Luxonis plans to deepen the OAK4 platform, scale production, and introduce new devices at accessible price points and flexible form factors. The company intends to expand R&D, go-to-market, and engineering-support teams to accelerate production deployments. Having raised a $14 million Series A, Luxonis aims to broaden supply-chain capacity and advance edge AI architectures to make its platform easier to adopt.
- MD Integrations
Led · Equity · Oct 2025
Founded in 2020 by quadruple board-certified physician Dr. Marc Serota, MD Integrations (MDI) has built an end-to-end, API-first telehealth platform that connects brands, physicians, pharmacies, diagnostics, and payments in a single system. Its nationwide, board-certified doctor network has already delivered millions of patient consults for hundreds of digital health brands spanning weight management, dermatology, women’s health, urgent care, and other high-demand specialties. Key features include built-in state-by-state compliance guardrails, turnkey or fully customizable workflows, and native integrations with Shopify and WooCommerce to speed partner launches from weeks to days. The company reports triple-digit year-over-year growth, underscoring strong market demand for physician-led virtual care infrastructure. With its growth-optimized data engine, MDI allows partners to easily expand into new specialties without rebuilding clinical operations. The firm plans to use new capital to deepen its physician network, expand pharmacy and diagnostics integrations, and accelerate product innovation. While specific revenue figures were not disclosed, the scale of consults and rapid growth trajectory indicate meaningful operating momentum.
- Tobin Scientific
Led · Equity · May 2025
Tobin Scientific provides cGMP-compliant storage, biorepository services and specialized transport and logistics for biopharma, including laboratory relocation, cold chain transport and cGMP warehousing. The company operates more than 365,000 square feet of cold chain and ambient warehouse space. Led by CEO Brian Tobin, Tobin serves life‑sciences customers and offers a broad portfolio of specialized transportation and storage services. The company says it will invest in advanced technologies and infrastructure to support evolving customer needs. Management plans to use the new capital to enhance cGMP storage and logistics capacity and accelerate its geographic footprint in key pharmaceutical hubs. The focus is on supporting the next phase of growth across operations and locations.
- HiLabs
Led · Series B · Mar 2024
HiLabs provides AI-powered solutions to clean dirty data for healthcare transformation. Its cloud-based MCheck platform ingests, cleans, and enriches critical healthcare information, resulting in significant reductions in healthcare organizations’ operational costs and improvements in patient outcomes. The technology supports some of the largest health insurance companies in the US in automating and improving administrative processes. Led by CEO Amit Garg, the company plans to use new funding to enhance its technology, recruit talent, and expand its product teams. HiLabs raised $39M in a Series B round to support those plans. The company is based in Bethesda, MD.
- Sollis Health
Led · Series A · Jan 2022
Sollis Health operates a high-touch medical membership model that provides members unlimited access to ER-trained physicians, onsite advanced imaging, and diagnostic capabilities around the clock. The company markets itself as the first urgent and emergency concierge care provider, eliminating wait times and complexities associated with conventional healthcare. Sollis currently operates centers in New York, the Hamptons, Los Angeles, San Francisco, and South Florida and plans new flagship and clinic openings in Texas, Miami, and Silicon Valley. Since its Series A in 2021 the company says membership has grown more than threefold, and it recently rolled out a nationwide Family membership tier and a Family+ tier in Los Angeles. Proceeds from the recent raise will fund nationwide expansion, product innovation, proprietary technology to enhance the member experience, and scaling of operations to meet growing demand. The company emphasizes 24/7 in-person and telehealth availability as a core differentiator for urgent and emergency issues. Sollis Health operates a membership model offering round-the-clock concierge urgent and emergency care through state-of-the-art medical centers and virtual visits. Its membership includes unlimited in-center and virtual visits, routine labs, wound care, certain procedures, expedited specialist referrals, and optional onsite advanced imaging and house calls. The company has opened flagship centers in Palm Beach and San Francisco and operates sites in New York City, The Hamptons, and Los Angeles. Sollis reports a 100% CAGR in membership since 2019 with annual retention rates approaching 90%. Management plans to use new capital to open five additional centers through 2024 and invest in technological and product enhancements to improve the patient and provider experience. To date the company has raised over $53 million in equity. Sollis Health operates medical concierge practices offering 24/7 urgent care, onsite labs, advanced imaging, virtual visits and in-home services, including monoclonal antibody treatment for Covid-19. Launched in New York in 2019, the company runs clinics in New York, Los Angeles, San Francisco, Miami and Palm Beach and staffs facilities with emergency medicine physicians. Sollis uses an annual membership model priced between $1,000–$5,000 per year that includes unlimited clinic visits and varying tiers by age. Financially, the company has achieved a revenue compound annual growth rate of 150% and maintains a long-run average 90% adjusted renewal rate, currently serving more than 8,000 patients. Sollis plans to grow to more than 12,000 patients within the next year and to expand patient reach in existing and new markets. Through its member-concierge and patient advocacy teams, Sollis secures expedited specialist visits and helps members navigate the broader medical system.
Team
Breanna McKeehan
Co-Founder and Managing Director
Jesse Lane
Founder and Managing Director
Alec Douglas
Senior Associate
LinkedInJesse Lane